New Leaf Venture (NLV) Partners is a life science-dedicated venture capital firm with offices in Menlo Park, CA and New York, NY. Founded by an experienced team of venture capitalists with deep healthcare industry experience, NLV Partners invests primarily in companies focused on clinical-stage biopharmaceutical products, early-stage medical devices, and molecular diagnostics. NLV Partners manages over $1.3 billion of assets, including NLV-I, NLV-II and the healthcare technology portfolio of Sprout Group.
Sprout Group is one of the oldest and largest institutional venture capital firms focused on emerging companies. Since its founding in 1969, Sprout Group has financed more than 350 companies and has raised nearly $3.0 billion in committed capital from leading institutional investors and individuals. In November 2000, Sprout Group closed Sprout IX, a fund totaling $1.1 billion. While Sprout IX's new investment phase has been completed and the fund's activities are confined to follow-on investments in existing portfolio companies, we are still interested in new investment opportunities for our associated funds: New Leaf Venture Partners is actively seeking opportunities in the healthcare technology sector; its focus is primarily on a later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies. Contact New Leaf Venture Partners at: info@nlvpartners.com
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory